Immunomonitoring of Stage IV Relapsed Neuroblastoma Patients Undergoing Haploidentical Hematopoietic Stem Cell Transplantation and Subsequent GD2 (ch14.18/CHO) Antibody Treatment

Haploidentical stem cell transplantation (haplo SCT) in Stage IV neuroblastoma relapsed patients has been proven efficacious, while immunotherapy utilizing the anti-GD2 antibody dinutuximab beta has become a standard treatment for neuroblastoma. The combinatorial therapy of haplo SCT and dinutuximab...

Descripción completa

Detalles Bibliográficos
Autores principales: Seitz, Christian Martin, Flaadt, Tim, Mezger, Markus, Lang, Anne-Marie, Michaelis, Sebastian, Katz, Marie, Syring, Desireé, Joechner, Alexander, Rabsteyn, Armin, Siebert, Nikolai, Troschke-Meurer, Sascha, Zumpe, Maxi, Lode, Holger N., Yang, Sile F., Atar, Daniel, Mast, Anna-Sophia, Scheuermann, Sophia, Heubach, Florian, Handgretinger, Rupert, Lang, Peter, Schlegel, Patrick
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8339919/
https://www.ncbi.nlm.nih.gov/pubmed/34367149
http://dx.doi.org/10.3389/fimmu.2021.690467

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8339919/
https://www.ncbi.nlm.nih.gov/pubmed/34367149
http://dx.doi.org/10.3389/fimmu.2021.690467

Ejemplares similares